These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34584142)

  • 1. Sarcopenia adversely impacts postoperative complications in living-donor liver transplantation recipients.
    Wu MY; Lim WX; Cheng YF; Chang CD; Hsu HW; Lin CC; Chen CL; Chang WC; Yu CY; Tsang LL; Chuang YH; Ou HY
    Sci Rep; 2021 Sep; 11(1):19247. PubMed ID: 34584142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia Affects Liver Regeneration and Long-Term Survival Rate After Living-Donor Liver Transplantation in Patients With Hepatocellular Carcinoma.
    Wu MY; Yeh CH; Liao CC; Chen CL; Wang CC; Lin CC; Chang WC; Cheng YF; Ou HY
    Transplant Proc; 2024 Apr; 56(3):573-580. PubMed ID: 38326205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation.
    Chae MS; Moon KU; Jung JY; Choi HJ; Chung HS; Park CS; Lee J; Choi JH; Hong SH
    Liver Transpl; 2018 May; 24(5):623-633. PubMed ID: 29365358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.
    Goldberg DS; Ruebner RL; Abt PL
    Am J Transplant; 2015 Oct; 15(10):2732-8. PubMed ID: 25969133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low psoas muscle index as an unfavorable factor in children with end-stage liver disease undergoing liver transplantation.
    Jitwongwai S; Lertudomphonwanit C; Junhasavasdikul T; Fuangfa P; Tanpowpong P; Gesprasert G; Treepongkaruna S
    Pediatr Transplant; 2021 Aug; 25(5):e13996. PubMed ID: 33734542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Causes and Outcomes of Early Relaparotomy Following Pediatric Living Donor Liver Transplantation.
    Okada N; Sanada Y; Onishi Y; Urahashi T; Ihara Y; Yamada N; Hirata Y; Katano T; Imai T; Ushijima K; Ogaki K; Otomo S; Mizuta K
    Liver Transpl; 2019 Jul; 25(7):1066-1073. PubMed ID: 30865366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative Changes in the Psoas Muscle Index in Patients Undergoing ABO-Incompatible Living-Donor Liver Transplantation: A Single-Center Experience.
    Chae MS; Kim Y; Kim J; Ko YR; Jung JY; Choi HJ; Chung HS; Hong SH; Park CS; Choi JH; Huh J
    Transplant Proc; 2018 Dec; 50(10):3656-3660. PubMed ID: 30577251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoas Muscle Index Does Not Predict Post-Transplant Outcomes: A Series of 57 Liver Transplant Recipients.
    Alconchel F; Martínez-Alarcón L; Nicolás-López T; Khiri F; Febrero B; Cascales-Campos PA; Martínez-Insfran LA; Ríos A; Fernández-Hernández JA; Rodríguez JM; López-López V; Sánchez-Bueno F; Robles-Campos R; Parrilla P; Ramírez P
    Transplant Proc; 2020 Mar; 52(2):549-552. PubMed ID: 32029312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Functional Frailty and Radiographic Sarcopenia as Predictors of Outcomes After Liver Transplant.
    Olson SL; Polineni P; Schwartz WAH; Thuluvath AJ; Duarte-Rojo A; Ladner DP
    Clin Transplant; 2024 Jul; 38(7):e15412. PubMed ID: 39049617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and Safety of Split-Liver Transplantation in a Nascent Framework of Deceased Donation.
    Cherukuru R; Reddy MS; Shanmugam NP; Rajalingam R; Kota V; Gunasekaran V; Narasimhan G; Kaliamoorthy I; Rela M
    Liver Transpl; 2019 Mar; 25(3):450-458. PubMed ID: 30586233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living Donor Liver Transplantation Using Selected Grafts With 2 Bile Ducts Compared With 1 Bile Duct Does Not Impact Patient Outcome.
    Kollmann D; Goldaracena N; Sapisochin G; Linares I; Selzner N; Hansen BE; Bhat M; Cattral MS; Greig PD; Lilly L; McGilvray ID; Ghanekar A; Grant DR; Selzner M
    Liver Transpl; 2018 Nov; 24(11):1512-1522. PubMed ID: 30264930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbid obesity in liver transplant recipients adversely affects longterm graft and patient survival in a single-institution analysis.
    Conzen KD; Vachharajani N; Collins KM; Anderson CD; Lin Y; Wellen JR; Shenoy S; Lowell JA; Doyle MB; Chapman WC
    HPB (Oxford); 2015 Mar; 17(3):251-7. PubMed ID: 25322849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right lobe living donors ages 55 years old and older in liver transplantation.
    Kim SH; Lee EC; Shim JR; Park SJ
    Liver Transpl; 2017 Oct; 23(10):1305-1311. PubMed ID: 28734130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Proper Graft Selection in Adult Living-Donor Liver Transplant Recipients with Preoperative Deteriorated Condition.
    Iida T; Masuda K; Matsuyama T; Harada S; Nakamura T; Koshino K; Suzuki T; Nobori S; Ushogome H; Ito T; Sakamoto S; Uryuhara K; Okajima H; Kaihara S; Uemoto S; Yoshimura N
    Ann Transplant; 2017 Sep; 22():541-549. PubMed ID: 28883387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation.
    Kuo SZ; Ahmad M; Dunn MA; Montano-Loza AJ; Carey EJ; Lin S; Moghe A; Chen HW; Ebadi M; Lai JC
    Transplantation; 2019 Nov; 103(11):2312-2317. PubMed ID: 30985575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation?
    Badawy A; Kaido T; Hamaguchi Y; Anazawa T; Yagi S; Fukumitsu K; Kamo N; Okajima H; Uemoto S
    Prog Transplant; 2018 Sep; 28(3):213-219. PubMed ID: 29902957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Tumor Necrosis Factor-α Is Inversely Associated With the Psoas Muscle Index in Both Male and Female Patients Scheduled for Living Donor Liver Transplantation.
    Shim JW; Yang S; Jung JY; Choi HJ; Chung HS; Hong SH; Park CS; Choi JH; Chae MS
    Transplant Proc; 2019; 51(6):1874-1879. PubMed ID: 31262437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.